Nautilus Biotechnolgy's total assets for Q2 2025 were $213.19M, a decrease of -6.37% from the previous quarter. NAUT total liabilities were $32.09M for the fiscal quarter, a -3.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.